Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

PRECISION investigators

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences